Ixaka and Minaris Regenerative Medicine Sign Tech Transfer and GMP Manufacturing Agreement for Lead Cell Therapy Candidate REX-001

The scope of the manufacturing agreement includes the scale-up and technology transfer with the goal of supplying the Phase 3 clinical trials and ...